Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression.

Kathy RobinsonZhe CaoKristin DelfinoDeliang CaoKrishna Rao

Published in: The Journal of international medical research (2023)

The findings are complex, but the overall data suggest that AKR1B10 is suitable as a tumor marker in patients with elevated levels at the time of diagnosis.

Keyphrases

poor prognosis
electronic health record
locally advanced
big data
binding protein
long non coding rna
squamous cell carcinoma
radiation therapy
rectal cancer
chemotherapy induced